Forum · Medicine · Story discussion
LCatlas: A Point-Of-Care Tool for Predicting Immunotherapy Outcomes in Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) remains a leading cause of cancer mortality, with a minority of patients experiencing durable responses to first-line immune checkpoint inhibitors (ICIs). Currently, there are no…
22 hours ago — medRxiv · Read the original
Peer reviews (0)
Comments (0)
No comments yet. Start the discussion.
Loading sign-in…